Digital therapeutics and their impact on society

Elisa del Galdo|14th January 2020

In the 20th century, research, technology and new novel treatments have enabled us to increase the average lifespan by 25 years, but our healthspan has not increased accordingly. We live longer, but not necessarily better – unfortunately, our quality of life has not improved throughout these added years. This is in part due to the explosive, bordering on unmanageable, increase in chronic diseases, such as cardiovascular disease, diabetes, Alzheimer’s disease, obesity and asthma.

Often these conditions are not experienced in isolation, resulting in many patients managing two or more comorbidities, leading to complex health problems that are more difficult to monitor and manage.

The World Health Organisation reports that by 2020 chronic diseases will account for three-quarters of all deaths worldwide and will reduce the quality of life for patients and their caregivers. With the average cost of managing comorbid chronic patients in the UK estimated to be eight times that of a relatively healthy patient, the economic impact of these illnesses on healthcare systems is immense.

To solve this problem, our systems must be more efficient and more effective in the management and prevention of chronic diseases.

Digital therapeutics, such as smartphone apps and wearable technology, can be used to relieve some of the pressure. They can be used in a multitude of ways to support the effective delivery of healthcare.

This includes monitoring, motivating, changing behaviour, facilitating communication, and helping to manage processes, all while collecting valuable data. When done well, these tools can facilitate more meaningful interactions between patients and healthcare professionals.

If our patients are diverse, why are clinical trials so white?

Ling Song|22nd June 2020

Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue and calls for the pharmaceutical industry to change its approach.

read more

How to run an engaging virtual workshop

Blue Latitude Health|15th June 2020

Our strategic consultants give their top tips for running an engaging virtual workshop. 

read more

Engaging physicians during COVID-19

Pany Koizi, Natasha Cowan|9th June 2020

COVID-19 has drastically changed the lives of healthcare professionals. They are emotionally and physically drained and under huge amounts of pressure. They also need pharma’s help. Senior Consultant Pany Koizi outlines five principles for engaging with physicians during the pandemic.

read more